Inactive Instrument

Insiders Kite Pharma Inc

Equities

Kite Pharma : Named to the MIT Technology Review's Annual 50 Smartest Companies List in Recognition for its Leadership in Establishing CAR-T Therapy	27/17/27	PU
Kite Pharma : Named to the MIT Technology Review’s Annual 50 Smartest Companies List in Recognition for its Leadership in Establishing CAR-T Therapy	27/17/27	BU
Kite Pharma : Richard L. Wang Named Chief Executive Officer of Fosun Kite Biotechnology Co., Ltd., a Joint Venture to Lead Development of Axicabtagene Ciloleucel and Other Engineered T-Cell Therapies for Treatment of Cancers in China	06/17/06	BU
Franz B. Humer, Former Chairman and CEO of Roche Group, Appointed to Kite Pharma's Board of Directors	15/15/15	GL

No results for this search